Literature DB >> 31463676

[Neuroprotection in neurocritical care].

Rainer Kollmar1.   

Abstract

In intensive care medicine neuroprotection is understood mostly as various measures to avoid secondary brain damage after initial trauma, as in stroke, intracranial hemorrhage and resuscitation. Every brain trauma differs in the damage pattern and dynamics depending on the primary form of injury. Therefore, there are targeted treatment approaches depending on the pathophysiology of the medical condition. In addition, neuroprotective methods are desirable that are effective in the majority of patients with acute brain injury. In actual fact, in all forms of acute brain injury certain pathophysiological courses are encountered, which can lead to secondary brain damage depending on the intensity, e.g. reperfusion injury, damage to the blood-brain barrier and excitotoxicity. There is evidence to suggest that the creation of physiologically normal conditions leads to a favorable situation for the damaged brain. This article firstly describes the relevance of neuroprotective measures in neurocritical care medicine. Subsequently, general pathophysiological mechanisms in brain trauma are described. Following this, the pathophysiology and treatment options in brain pressure crises (reduction of intracranial pressure), anemia (transfusion management), hyperglycemia and hypoglycemia (adjustment of the blood sugar level) are dealt with. Finally, the use and benefits of therapeutic hypothermia are discussed. This has a special position as the only clinically effective individual measure for neuroprotection. The focus here is on the application following circulatory and cardiac arrest and resuscitation.

Entities:  

Keywords:  Hypothermia, induced; Intracranial pressure; Resuscitation; Stroke; Subarachnoid hemorrhage

Mesh:

Year:  2019        PMID: 31463676     DOI: 10.1007/s00063-019-00608-8

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  27 in total

1.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

Review 2.  Cerebral Edema and Elevated Intracranial Pressure.

Authors:  Matthew A Koenig
Journal:  Continuum (Minneap Minn)       Date:  2018-12

3.  Intensive insulin therapy in the medical ICU.

Authors:  Greet Van den Berghe; Alexander Wilmer; Greet Hermans; Wouter Meersseman; Pieter J Wouters; Ilse Milants; Eric Van Wijngaerden; Herman Bobbaers; Roger Bouillon
Journal:  N Engl J Med       Date:  2006-02-02       Impact factor: 91.245

4.  Targeted temperature management at 33°C versus 36°C after cardiac arrest.

Authors:  Niklas Nielsen; Jørn Wetterslev; Tobias Cronberg; David Erlinge; Yvan Gasche; Christian Hassager; Janneke Horn; Jan Hovdenes; Jesper Kjaergaard; Michael Kuiper; Tommaso Pellis; Pascal Stammet; Michael Wanscher; Matt P Wise; Anders Åneman; Nawaf Al-Subaie; Søren Boesgaard; John Bro-Jeppesen; Iole Brunetti; Jan Frederik Bugge; Christopher D Hingston; Nicole P Juffermans; Matty Koopmans; Lars Køber; Jørund Langørgen; Gisela Lilja; Jacob Eifer Møller; Malin Rundgren; Christian Rylander; Ondrej Smid; Christophe Werer; Per Winkel; Hans Friberg
Journal:  N Engl J Med       Date:  2013-11-17       Impact factor: 91.245

5.  A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study.

Authors:  Jean-Charles Preiser; Philippe Devos; Sergio Ruiz-Santana; Christian Mélot; Djillali Annane; Johan Groeneveld; Gaetano Iapichino; Xavier Leverve; Gérard Nitenberg; Pierre Singer; Jan Wernerman; Michael Joannidis; Adela Stecher; René Chioléro
Journal:  Intensive Care Med       Date:  2009-07-28       Impact factor: 17.440

Review 6.  Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients.

Authors:  Andrew Retter; Duncan Wyncoll; Rupert Pearse; Damien Carson; Stuart McKechnie; Simon Stanworth; Shubha Allard; Dafydd Thomas; Tim Walsh
Journal:  Br J Haematol       Date:  2012-12-27       Impact factor: 6.998

7.  The global and regional burden of stroke.

Authors:  Graeme J Hankey
Journal:  Lancet Glob Health       Date:  2013-10-24       Impact factor: 26.763

8.  Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2).

Authors:  Patrick Lyden; Thomas Hemmen; James Grotta; Karen Rapp; Karin Ernstrom; Teresa Rzesiewicz; Stephanie Parker; Mauricio Concha; Syed Hussain; Sachin Agarwal; Brett Meyer; Julie Jurf; Irfan Altafullah; Rema Raman
Journal:  Stroke       Date:  2016-11-10       Impact factor: 7.914

9.  Early effects of acid-base management during hypothermia on cerebral infarct volume, edema, and cerebral blood flow in acute focal cerebral ischemia in rats.

Authors:  Rainer Kollmar; Thomas Frietsch; Dimitrios Georgiadis; Wolf-Rüdiger Schäbitz; Klaus F Waschke; Wolfgang Kuschinsky; Stefan Schwab
Journal:  Anesthesiology       Date:  2002-10       Impact factor: 7.892

Review 10.  Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis.

Authors:  Andreas H Kramer; Derek J Roberts; David A Zygun
Journal:  Crit Care       Date:  2012-10-22       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.